ADA: GLP-1 Receptor Agonist Use Beneficial in Adults With Obesity, Autoimmune Disease MONDAY, June 8, 2026 -- Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with reduced risks for thromboembolic events, emergency department use, and mortality among adults with obesity and autoimmune diseases (AIDs), according to a study published online June 6 in the Journal of the American Heart Association to coincide with the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans
Finally, if your eating schedule is chaotic
69,70,71 During life, organisms commonly face various sources of stress from the external environment and internal cellular factors
Characterization of the antibacterial activity of Balds eyesalve against drug resistant Staphylococcus aureus and Pseudomonas aeruginosa
Our team combines advanced training with a compassionate, patient-first approach to guide every step of your healing journey